{
    "clinical_study": {
        "@rank": "75641", 
        "arm_group": {
            "arm_group_label": "Low Frequency Therapeutic Ultrasound", 
            "arm_group_type": "Experimental", 
            "description": "Low Frequency Therapeutic Ultrasound (LOTUS) applied transcutaneously"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out what effect, if any, Low Frequency Therapeutic\n      Ultrasound (LOTUS) has on kidney function in patients with chronic kidney disease."
        }, 
        "brief_title": "Effect of Low Frequency Ultrasound on Kidney Function", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Kidney Disease", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Must be >/= 18 years of age\n\n          -  Must have documented Stage 3 to Stage 4 (eGFR 15 - 59) chronic kidney disease\n\n          -  Females with childbearing potential must not be pregnant at the time of study\n\n          -  Subject must provide written informed consent\n\n        Exclusion Criteria:\n\n          -  Unable or unwilling to cooperate with study procedures\n\n          -  Currently enrolled in another clinical study for which the follow-up period is not\n             complete"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02026544", 
            "org_study_id": "PRO-0001"
        }, 
        "intervention": {
            "arm_group_label": "Low Frequency Therapeutic Ultrasound", 
            "description": "29 kHz (kilohertz) low frequency therapeutic ultrasound delivered transcutaneously", 
            "intervention_name": "Low Frequency Therapeutic Ultrasound", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "low frequency ultrasound", 
            "glomerular filtration rate"
        ], 
        "lastchanged_date": "December 31, 2013", 
        "location": {
            "contact": {
                "email": "emily.verdin@ucsf.edu", 
                "last_name": "Emily Verdin", 
                "phone": "415-353-9437"
            }, 
            "facility": {
                "address": {
                    "city": "San Francisco", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94107"
                }, 
                "name": "Department of Radiology and Biomedical Imaging, UCSF"
            }, 
            "investigator": {
                "last_name": "Randall A Hawkins, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of the Effect of Low Frequency Therapeutic Ultrasound (LOTUS) on Kidney Function in Chronic Kidney Disease", 
        "other_outcome": [
            {
                "description": "Occurrence of cutaneous injury, such as erythema, blistering or rash occuring below the site of transducer placement", 
                "measure": "Cutaneous Injury", 
                "safety_issue": "Yes", 
                "time_frame": "5 minutes after LOTUS intervention"
            }, 
            {
                "description": "Heart rate will be measured at baseline, during LOTUS intervention, and immediately after LOTUS intervention has ended.", 
                "measure": "Heart rate", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 15 minutes after start of Intervention, and 5 minutes after end of intervention."
            }
        ], 
        "overall_contact": {
            "email": "emily.verdin@ucsf.edu", 
            "last_name": "Emily Verdin", 
            "phone": "415-353-9437"
        }, 
        "overall_official": {
            "affiliation": "University of California, San Francisco", 
            "last_name": "Randall A Hawkins, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Absolute change in glomerular filtration rate, GFR, measured by Tc-99m DTPA (diethylenetriamine pentaacetic acid) imaging (Gates Method) in the treated kidney(s) from baseline to during LOTUS", 
            "measure": "Glomerular Filtration Rate (GFR)", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 15 minutes after start of Intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02026544"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Percent change in GFR in the treated kidney(s) from baseline to during LOTUS.", 
                "measure": "Percent change in GFR", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 15 minutes after start of Intervention"
            }, 
            {
                "description": "Blood pressure is measured at baseline, during LOTUS intervention, and immediately after LOTUS intervention", 
                "measure": "Blood Pressure", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 15 minutes after start of Intervention, and 5 minutes after end of intervention"
            }
        ], 
        "source": "Sonogenix", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sonogenix", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}